Combined evaluation of NGF and p75NGFR expression is a biomarker for predicting prognosis in human invasive ductal breast carcinoma.

Sakamoto, Y; Kitajima, Y; Edakuni, G; Hamamoto, T; Miyazaki, K

Sakamoto, Y; Kitajima, Y; Edakuni, G; Hamamoto, T; Miyazaki, K.

Affiliation

Sakamoto Y; Department of Surgery, Saga Medical School, Saga 849-8501, Japan. dragonsakura@hotmail.com

Oncol Rep ; 8(5): 973-80, 2001.

Article in En | MEDLINE | ID: mdl-11496301

Subject(s)

Biomarkers, Tumor/metabolism; Breast Neoplasms/metabolism; Carcinoma, Ductal, Breast/metabolism; Nerve Growth Factors/metabolism; Receptors, Nerve Growth Factor/metabolism; Adult; Aged; Aged, 80 and over; Breast Neoplasms/diagnosis; Breast Neoplasms/mortality; Carcinoma, Ductal, Breast/diagnosis; Carcinoma, Ductal, Breast/mortality; Cell Division/physiology; Disease-Free Survival; Female; Humans; Immunoenzyme Techniques; Middle Aged; Mitotic Index; Multivariate Analysis; Prognosis; Receptor, Nerve Growth Factor; Receptor, trkA/metabolism; Survival Rate

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Biomarkers, Tumor / Receptors, Nerve Growth Factor / Carcinoma, Ductal, Breast / Nerve Growth Factors Type of study: Diagnostic_studies / Evaluation_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Oncol Rep Journal subject: NEOPLASIAS Year: 2001 Document type: Article Affiliation country: Japan Country of publication: Greece

Search on Google

Add to My VHL

XML

PubMed Links